Results 161 to 170 of about 7,998 (258)
Brain and Behavior, Volume 16, Issue 6, June 2026.Our integrative Mendelian randomization framework revealed that specific circulating metabolites exert causal effects on major depressive disorder, partly through immune‐cell–mediated pathways. These findings highlight metabolite–immune interactions as potential mechanistic targets for MDD prevention and therapy.
Zhiwei Xu +8 more
wiley +1 more source
Brain and Behavior, Volume 16, Issue 6, June 2026.Across Gli3+/Δ699, Gli2+/−, and combined Gli2+/−;Gli3+/Δ699 mice (males and females, with wild‐type controls), GLI2 and GLI3 differentially regulate anogenital distance and juvenile behavior, with amplified effects under combined disruption, whereas circulating steroids and sexually dimorphic nucleus area remain unchanged. Created in BioRender. Niepsuj,
Thomas Niepsuj +6 more
wiley +1 more source
Brain and Behavior, Volume 16, Issue 6, June 2026.ABSTRACT Purpose Psychedelics have received considerable attention due to their potential in treating psychiatric disorders. The “setting” during psychedelic‐assisted therapy (PAT) is recognized as playing a central role in the experience, during which music features prominently. Although music is theorized as directing and shaping psychedelic sessions,
T. Rowe +4 more
wiley +1 more source
Anhedonia. Mylene Fernández Pintado
, 1999 Obra ressenyada: Mylene FERNÁNDEZ PINTADO, Anhedonia.
Tamayo, Caridad
core
Brain and Behavior, Volume 16, Issue 6, June 2026.The study investigated the association between systemic inflammation response index (SIRI) and individual depressive symptoms. Multivariable‐adjusted associations between SIRI and symptoms of anhedonia, sleep disturbance, fatigue, and appetite changes were reported.
Moshui Shan +4 more
wiley +1 more source
Brain and Behavior, Volume 16, Issue 6, June 2026.In this review, we discuss the scientific basis for how neurocognitive aging occurs after critical illness, including sepsis, trauma, and burns, and the clinical need to develop therapies to reduce inflammation, protect the blood–brain barrier, remove senescent cells, and enhance neuroplasticity.
Errin Lawrence +14 more
wiley +1 more source
Brain and Behavior, Volume 16, Issue 6, June 2026.Individuals with treatment‐resistant depression considering psychedelic trial participation were motivated by chronic illness, failed treatments, and hope for a novel intervention, while actively minimizing expectations to guard against disappointment.
Christopher Poppe +3 more
wiley +1 more source
Cancer Medicine, Volume 15, Issue 6, June 2026.ABSTRACT Background The Hospital Anxiety and Depression Scale (HADS) is a widely used instrument for assessing anxiety and depression in cancer patients. However, the best factor structure for an oncological setting depending on the time of diagnosis is still unclear. Aim The objective of this study was to investigate the factor structure of the German‐
Thilo Dietz +6 more
wiley +1 more source
Clinical Case Reports, Volume 14, Issue 6, June 2026.ABSTRACT Hemolacria is a rare condition characterized by bloody tears. Its etiology is often multifactorial, but functional/psychosomatic mechanisms have been proposed when organic causes are excluded. A 48‐year‐old woman with a history of multiple traumatic brain injuries (coma in 2008, car accident in 2017) presented with refractory generalized ...
Roghayeh Mohammadi, Ahmad Alipour
wiley +1 more source
Pediatric Wilson Disease in Sudan: A Rare Case, Sudan Conflict and Diagnostic Challenges
Clinical Case Reports, Volume 14, Issue 6, June 2026.ABSTRACT Wilson disease is rarely reported among African children. Wilson disease is due to a mutation in ATP7B on an autosomal recessive pattern, which causes defective copper excretion and copper accumulation in tissues such as liver and brain.
Amjed Abdu Ali Mohammed +8 more
wiley +1 more source